Astellas Pharma Inc. (TYO:4503)
Japan · Delayed Price · Currency is JPY 2,125.50
-27.00 (-1.25%)
Jun 16, 2026, 12:50 PM JST
Astellas Pharma Market Cap
Astellas Pharma has a market cap or net worth of 3.86 trillion as of June 15, 2026. Its market cap has increased by 56.10% in one year.
Market Cap
3.86T
Enterprise Value
4.14T
Revenue
2.14T
Ranking
n/a
PE Ratio
13.27
Stock Price
2,125.50
Market Cap Chart
Since January 14, 1992, Astellas Pharma's market cap has increased from 882.84B to 3.86T, an increase of 336.79%. That is a compound annual growth rate of 4.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 3.86T | 2.86% |
| Dec 30, 2025 | 3.75T | 36.48% |
| Dec 30, 2024 | 2.75T | -9.13% |
| Dec 29, 2023 | 3.02T | -17.34% |
| Dec 30, 2022 | 3.66T | 5.52% |
| Dec 30, 2021 | 3.47T | 17.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.26T |
| Otsuka Holdings | 5.37T |
| Daiichi Sankyo Company | 4.55T |
| Kyowa Kirin | 1.26T |
| Ono Pharmaceutical | 1.04T |
| Santen Pharmaceutical | 618.75B |
| JCR Pharmaceuticals | 54.77B |
| Perseus Proteomics | 2.48B |